Search

everythinglearnresearchcommunity

for

Search:↓

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Medications for PCOS don't seem to raise heart disease risk.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Women with polycystic ovarian syndrome often experience depression and anxiety.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Classical PCOS types A and B are most common and linked to higher health risks.

Women with different PCOS types have similar fertility treatment results.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Creating specific biological indicators is important for early detection and treatment of PCOS.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.